Cell–extracellular matrix mechanotransduction in 3D
Nature Reviews Molecular Cell Biology,
Journal Year:
2023,
Volume and Issue:
24(7), P. 495 - 516
Published: Feb. 27, 2023
Language: Английский
The role of lipids in cancer progression and metastasis
Miguel Martín‐Pérez,
No information about this author
Uxue Urdiroz-Urricelqui,
No information about this author
Claudia Bigas
No information about this author
et al.
Cell Metabolism,
Journal Year:
2022,
Volume and Issue:
34(11), P. 1675 - 1699
Published: Oct. 18, 2022
Language: Английский
Decellularization in Tissue Engineering and Regenerative Medicine: Evaluation, Modification, and Application Methods
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2022,
Volume and Issue:
10
Published: April 25, 2022
Reproduction
of
different
tissues
using
scaffolds
and
materials
is
a
major
element
in
regenerative
medicine.
The
regeneration
whole
organs
with
decellularized
extracellular
matrix
(dECM)
has
remained
goal
despite
the
use
these
for
purposes.
Recently,
decellularization
techniques
have
been
widely
used
producing
that
are
appropriate
regenerating
damaged
may
be
able
to
overcome
shortage
donor
organs.
Decellularized
ECM
offers
several
advantages
over
synthetic
compounds,
including
preserved
natural
microenvironment
features.
Different
methods
developed,
each
which
removing
cells
from
specific
under
certain
conditions.
A
variety
advanced
evaluating
process
terms
cell
removal
efficiency,
tissue
ultrastructure
preservation,
toxicity,
biocompatibility,
biodegradability,
mechanical
resistance
order
enhance
efficacy
methods.
Modification
improve
characteristics
scaffolds,
making
them
available
tissues.
Moreover,
modification
makes
options
drug
delivery,
disease
modeling,
improving
stem
growth
proliferation.
However,
considering
challenges
way
application
this
field
constantly
developing
progressively
moving
forward.
This
review
outlined
recent
sterilization
strategies,
evaluation
tests
efficient
decellularization,
processing,
application,
future
outlooks
medicine
engineering.
Language: Английский
Decellularization for the retention of tissue niches
Journal of Tissue Engineering,
Journal Year:
2022,
Volume and Issue:
13
Published: Jan. 1, 2022
Decellularization
of
natural
tissues
to
produce
extracellular
matrix
is
a
promising
method
for
three-dimensional
scaffolding
and
understanding
microenvironment
the
tissue
interest.
Due
lack
universal
standard
protocol
decellularization,
recent
investigations
seek
develop
novel
methods
whole
or
partial
organ
decellularization
capable
supporting
cell
differentiation
implantation
towards
appropriate
regeneration.
This
review
provides
comprehensive
updated
perspective
on
most
advances
in
strategies
variety
organs
tissues,
highlighting
techniques
chemical,
physical,
biological,
enzymatic,
combinative-based
remove
cellular
contents
from
tissues.
In
addition,
presents
modernized
approaches
improving
protocols
numerous
types.
Language: Английский
Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment
Nature Cancer,
Journal Year:
2024,
Volume and Issue:
5(7), P. 1045 - 1062
Published: June 3, 2024
Language: Английский
Collagens in Cancer: Structural Regulators and Guardians of Cancer Progression
Cancer Research,
Journal Year:
2023,
Volume and Issue:
83(9), P. 1386 - 1392
Published: Jan. 13, 2023
Abstract
Collagen
is
one
of
the
most
abundant
proteins
in
animals
and
a
major
component
extracellular
matrix
(ECM)
tissues.
Besides
playing
role
as
structural
building
block
tissues,
collagens
can
modulate
behavior
cells,
their
deregulation
promote
diseases
such
cancer.
In
tumors,
many
other
ECM
molecules
are
mainly
produced
by
fibroblasts,
recent
evidence
points
toward
tumor-derived
tumor
progression
metastasis.
this
review,
we
focus
on
newly
discovered
functions
Novel
findings
have
revealed
dormancy
immune
evasion,
well
interplay
with
cancer
cell
metabolism.
Collagens
could
serve
prognostic
markers
for
patients
cancer,
therapeutic
strategies
targeting
collagen
potential
to
prevent
Language: Английский
Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives
Molecular & Cellular Proteomics,
Journal Year:
2023,
Volume and Issue:
22(4), P. 100528 - 100528
Published: March 12, 2023
•ECM
alterations
cause
or
accompany
diseases
and
disorders
of
all
organ
systems.•Proteomics
is
a
method
choice
to
profile
the
composition
ECM
tissues.•ECM
proteomics
can
identify
novel
prognostic
diagnostic
biomarkers.•ECM
uncover
proteins
playing
functional
roles
in
disease
etiology.•Further
technical
advances
are
needed
capture
diversity
proteoforms
The
extracellular
matrix
(ECM)
complex
assembly
hundreds
forming
architectural
scaffold
multicellular
organisms.
In
addition
its
structural
role,
conveys
signals
orchestrating
cellular
phenotypes.
Alterations
composition,
abundance,
structure,
mechanics
have
been
linked
affecting
physiological
systems,
including
fibrosis
cancer.
Deciphering
protein
how
it
changes
pathophysiological
contexts
thus
first
step
toward
understanding
health
development
therapeutic
strategies
correct
disease-causing
alterations.
Potentially,
also
represents
vast,
yet
untapped
reservoir
biomarkers.
characterized
by
unique
biochemical
properties
that
hindered
their
study:
they
large,
heavily
uniquely
posttranslationally
modified,
highly
insoluble.
Overcoming
these
challenges,
we
others
devised
mass-spectrometry–based
proteomic
approaches
define
"matrisome,"
tissues.
This
part
this
review
provides
historical
overview
research
presents
latest
now
allow
profiling
healthy
diseased
second
highlights
recent
examples
illustrating
has
emerged
as
powerful
discovery
pipeline
cancer
third
discusses
remaining
challenges
limiting
our
ability
translate
findings
clinical
application
proposes
overcome
them.
Lastly,
introduces
readers
resources
available
facilitate
interpretation
datasets.
was
once
thought
be
impenetrable.
Mass
spectrometry–based
proven
tool
decode
ECM.
light
progress
made
over
past
decade,
there
reasons
believe
in-depth
exploration
matrisome
within
reach
may
soon
witness
translational
proteomics.
organisms
(1Hynes
R.O.
evolution
metazoan
matrix.J.
Cell
Biol.
2012;
196:
671-679Crossref
PubMed
Scopus
(177)
Google
Scholar,
2Adams
J.C.
Extracellular
evolution:
an
overview.in:
Keeley
F.W.
Mecham
R.P.
Evolution
Matrix.
Springer,
Berlin,
Heidelberg2013:
1-25https://doi.org/10.1007/978-3-642-36002-2_1Crossref
3Karamanos
N.K.
Theocharis
A.D.
Piperigkou
Z.
Manou
D.
Passi
A.
Skandalis
S.S.
et
al.A
guide
functions
matrix.FEBS
J.
2021;
288:
6850-6912Crossref
(34)
Scholar).
As
such,
guides
cell
polarization
serves
substrate
migration,
organizes
cells
into
tissues
organs,
confers
mechanical
roles,
exerts
signaling
through
mechanotransduction
(4Humphrey
J.D.
Dufresne
E.R.
Schwartz
M.A.
Mechanotransduction
homeostasis.Nat.
Rev.
Mol.
2014;
15:
802-812Crossref
(1185)
5Dooling
L.J.
Saini
K.
Anlaş
A.A.
Discher
D.E.
Tissue
coevolves
with
fibrillar
matrisomes
fibrotic
tissues.Matrix
2022;
111:
153-188Crossref
(0)
It
cues
interpreted
via
cell-surface
receptors
(e.g.,
integrins
(6Kanchanawong
P.
Calderwood
D.A.
Organization,
dynamics
mechanoregulation
integrin-mediated
cell–ECM
adhesions.Nat.
24:
142-161Crossref
(7)
Scholar),
syndecans,
adhesion
GPCRs
(7Liebscher
I.
Cevheroğlu
O.
Hsiao
C.C.
Maia
A.F.
Schihada
H.
Scholz
N.
GPCR
research.FEBS
289:
7610-7630Crossref
(5)
Scholar))
orchestrate
most,
if
not
all,
functions,
from
proliferation
survival
stemness
differentiation.
plays
critical
during
development,
growth,
other
processes
wound
healing
aging
(8Yamada
K.M.
Collins
J.W.
Cruz
Walma
Doyle
Morales
S.G.
Lu
al.Extracellular
invasion
tissue
morphogenesis.Int.
Exp.
Pathol.
2019;
100:
144-152Crossref
(47)
9Dzamba
B.J.
DeSimone
D.W.
sculpting
embryonic
tissues.Curr.
Top
Dev.
2018;
130:
245-274Crossref
(49)
10Karamanos
Neill
T.
Iozzo
R.V.
Matrix
modeling
remodeling:
biological
interplay
regulating
homeostasis
diseases.Matrix
75–76:
1-11Crossref
(156)
11Lausecker
F.
Lennon
R.
Randles
M.J.
kidney
health,
aging,
disease.Kidney
Int.
102:
1000-1012Abstract
Full
Text
PDF
(1)
12Ewald
C.Y.
longevity:
systems-level
approach
defining
matreotypes
promoting
aging.Gerontology.
2020;
66:
266-274Crossref
(31)
Simply
put,
essential
for
life.
dynamic
compartment
undergoes
compositional
turnover
remodeling
mediated
both
enzymatic
nonenzymatic
processes.
Disruption
homeostasis,
caused
mutations
genes
(13Lamandé
S.R.
Bateman
J.F.
Genetic
matrix.Anat.
Rec.
(Hoboken).
303:
1527-1542Crossref
imbalance
between
production
degradation,
inadequate
remodeling,
results
systems
(14Lu
Takai
Weaver
V.M.
Werb
degradation
disease.Cold
Spring
Harb.
Perspect.
2011;
3:
a005058Crossref
(1375)
15Bonnans
C.
Chou
Remodelling
disease.Nat.
786-801Crossref
(2349)
16Theocharis
Karamanos
multitasking
player
disease.FEBS
286:
2830-2869Crossref
(190)
Scholar)
musculoskeletal
system
Ehlers–Danlos
syndrome
(17Malfait
Castori
M.
Francomano
C.A.
Giunta
Kosho
Byers
P.H.
Ehlers-Danlos
syndromes.Nat.
Dis.
Primers.
6:
64Crossref
(82)
arthritis),
skin
scleroderma
(18Schulz
J.N.
Plomann
Sengle
G.
Gullberg
Krieg
Eckes
B.
New
developments
on
-
emanating
control
myofibroblasts.Matrix
68–69:
522-532Crossref
(48)
epidermolysis
bullosa
(19Bruckner-Tuderman
L.
Has
Disorders
cutaneous
basement
membrane
zone--the
paradigm
bullosa.Matrix
33:
29-34Crossref
Scholar)),
cardiovascular
Marfan
(20Cook
J.R.
Carta
Galatioto
Ramirez
Cardiovascular
manifestations
related
diseases;
multiple
causing
similar
phenotypes.Clin.
Genet.
2015;
87:
11-20Crossref
(52)
respiratory
(lung
(21Zhou
Y.
Horowitz
Naba
Ambalavanan
Atabai
Balestrini
lung
disease.Matrix
73:
77-104Crossref
(138)
excretory
Alport
syndrome,
Goodpasture
renal
(22Bülow
R.D.
Boor
fibrosis:
more
than
just
scaffold.J.
Histochem.
Cytochem.
67:
643-661Crossref
(134)
23Chew
Basement
defects
genetic
diseases.Front.
Pediatr.
11Crossref
(50)
list
few.
addition,
excessive
accumulation
hallmark
(24Pakshir
Hinz
big
five
macrophages,
myofibroblasts,
matrix,
mechanics,
miscommunication.Matrix
81-93Crossref
(211)
(25Pickup
M.W.
Mouw
J.K.
modulates
hallmarks
cancer.EMBO
Rep.
1243-1253Crossref
(1078)
26Cox
T.R.
cancer.Nat.
Cancer.
21:
217-238Crossref
(222)
27Winkler
Abisoye-Ogunniyan
Metcalf
K.J.
Concepts
remodelling
tumour
progression
metastasis.Nat.
Commun.
11:
5120Crossref
(584)
extent
deposition
context
cancer,
assessed
tumor:stroma
ratio,
shown
value
patients
colorectal
(28Souza
da
Silva
R.M.
Queiroga
E.M.
Paz
A.R.
Neves
F.F.P.
Cunha
K.S.
Dias
E.P.
Standardized
assessment
tumor-stroma
ratio
cancer:
interobserver
validation
reproducibility
potential
factor.Clin.
14https://doi.org/10.1177/2632010X21989686Crossref
29van
Pelt
G.W.
Sandberg
T.P.
Morreau
Gelderblom
van
Krieken
J.H.J.M.
Tollenaar
R.A.E.M.
al.The
tumour-stroma
colon
role
impact.Histopathology.
197-206Crossref
Nine
70-gene
MammaPrint
panel
used
early
breast
diagnosis
(30Cardoso
van't
Veer
Bogaerts
Slaets
Viale
Delaloge
S.
al.70-Gene
signature
aid
treatment
decisions
early-stage
cancer.N.
Engl.
Med.
2016;
375:
717-729Crossref
genes.
present
advantage
being
readily
accessible,
outside
cells.
Consequently,
targeted
delivery
imaging
agents
(31Jailkhani
Ingram
Rashidian
Rickelt
Tian
Mak
al.Noninvasive
tumor
progression,
metastasis,
using
nanobody
targeting
matrix.Proc.
Nat.
Acad.
Sci.
U.
116:
14181-14190Crossref
32Santimaria
Moscatelli
G.L.
Giovannoni
Neri
Viti
al.Immunoscintigraphic
detection
ED-B
domain
fibronectin,
marker
angiogenesis,
cancer.Clin.
Cancer
Res.
2003;
9:
571-579PubMed
33Steiner
Antibody-radionuclide
conjugates
therapy:
considerations
new
trends.Clin.
17:
6406-6416Crossref
(125)
drugs,
example,
bispecific
composed
moiety
recognizing
disease-specific
immunomodulatory
cytokine
(34Pasche
Immunocytokines:
class
potent
armed
antibodies.Drug
Discov.
Today.
583-590Crossref
(129)
35Lieverse
R.I.Y.
Van
Limbergen
E.J.
Oberije
C.J.G.
Troost
E.G.C.
Hadrup
Dingemans
A.M.C.
al.Stereotactic
ablative
body
radiotherapy
(SABR)
combined
immunotherapy
(L19-IL2)
versus
standard
care
stage
IV
NSCLC
patients,
ImmunoSABR:
multicentre,
randomised
controlled
open-label
phase
II
trial.BMC
20:
557Crossref
36Momin
Mehta
Bennett
N.R.
Ma
Palmeri
Chinn
M.M.
al.Anchoring
intratumorally
administered
cytokines
collagen
safely
potentiates
systemic
immunotherapy.Sci.
Transl.
11eaaw2614Crossref
(98)
proposed
modulating
architecture
biophysical
ECM–cell
interactions
could
valid
various
(37Nyström
Bernasconi
Bornert
Therapies
skin.Matrix
71–72:
330-347Crossref
(18)
38Schuppan
Ashfaq-Khan
Yang
A.T.
Kim
Y.O.
Liver
direct
antifibrotic
therapies.Matrix
435-451Crossref
(244)
39Bejarano
Jordāo
M.J.C.
Joyce
J.A.
Therapeutic
microenvironment.Cancer
933-959Crossref
(274)
40Hauge
Rofstad
E.K.
Antifibrotic
therapy
normalize
microenvironment.J.
18:
207Crossref
(40)
41Lampi
M.C.
Reinhart-King
Targeting
stiffness
attenuate
disease:
molecular
mechanisms
trials.Sci.
10eaao0475Crossref
(279)
42Ley
Rivera-Nieves
Sandborn
W.J.
Shattil
Integrin-based
therapeutics:
basis,
use
drugs.Nat.
Drug
173-183Crossref
(273)
constitutes
large
biomarkers
targets.
Yet,
while
some
elastin)
families
collagens,
tenascins)
extensively
studied,
whole,
remained,
until
recently,
largely
underexplored
(43Wilson
matrix:
but
important
proteome.Expert
Proteomics.
2010;
7:
803-806Crossref
(14)
uncharted
(44Filipe
E.C.
Chitty
J.L.
Cox
Charting
unexplored
cancer.Int.
99:
58-76Crossref
very
allowing
assemble
capable
withstanding
significant
stress
deformations
study
global
core,
tend
average
1045
amino
acids
long.
undergo
extensive
intracellular
posttranslational
modifications
(PTMs),
glycosylation,
lysine
proline
hydroxylation
collagens
collagen-domain-containing
contribute
stabilization
triple-helical
structure
(45Rappu
Salo
A.M.
Myllyharju
Heino
Role
prolyl
collagens.Essays
Biochem.
63:
325-335Crossref
glycation.
higher-order
structures
established
hydrogen
bonds
(46Buehler
Nature
designs
tough
collagen:
explaining
nanostructure
fibrils.Proc.
Natl.
2006;
103:
12285-12290Crossref
(593)
47Shoulders
M.D.
Raines
R.T.
Collagen
stability.Annu.
2009;
78:
929-958Crossref
(2243)
disulfide
fibronectin
dimers
(48Schwarzbauer
J.E.
Fibronectins,
fibrillogenesis,
vivo
functions.Cold
2011
Jul
1;
a005041Crossref
(280)
covalent
cross-links
elastin
(49Ozsvar
Cain
S.A.
Baldock
Tarakanova
Weiss
A.S.
Tropoelastin
assembly.Front.
Bioeng.
Biotechnol.
9643110Crossref
(35)
(50Ricard-Blum
family.Cold
a004978Crossref
(1080)
Scholar)).
These
making
insoluble
and,
hence,
challenging
like
SDS-PAGE,
immunoprecipitation
pull-down
assays
mass
spectrometry
(MS).
Because
high
insolubility,
underrepresented
Further
contributing
underrepresentation
fact
that,
apart
few
exceptions,
small
fraction
mass.
challenge
comprehensive
characterization
broad
range
terms
abundance.
comprised
abundant
components,
which
generate
many
peptides
(for
121
trypsin
cleavage
sites
alpha
1
chain
I),
smaller
secreted
factors,
such
ECM-remodeling
enzymes,
growth
morphogens,
much
lower
limitation
ECM,
instrumentations
methods
fractionate
peptide
samples,
will
discussed
here,
key
complexity
different
subproteomes
applied
(see
below).
attempts
at
ECM-rich
tissues,
cartilage,
following
enrichment
employed
SDS-PAGE
2D
gel
electrophoresis
separate
subsets
solubilized,
followed
liquid
chromatography
coupled
tandem
(LC-MS/MS).
studies
reported
up
dozen
proteins.
At
time,
no
feat
instrumental
helping
shape
field
(51Wilson
Cartilage
proteomics:
solutions
advances.Proteomics
Clin.
Appl.
2008;
2:
251-263Crossref
52Lammi
Häyrinen
Mahonen
Proteomic
analysis
cartilage-
bone-associated
samples.Electrophoresis.
27:
2687-2701Crossref
53Hattar
Maller
McDaniel
Hansen
K.C.
Hedman
Lyons
al.Tamoxifen
induces
pleiotrophic
mammary
stroma
resulting
suppresses
transformed
phenotypes.Breast
R5Crossref
(53)
54Wilson
Diseberg
Gordon
Zivkovic
Tatarczuch
Mackie
al.Comprehensive
cartilage
formation
maturation
sequential
extraction
label-free
quantitative
proteomics.Mol.
1296-1313Abstract
(63)
55Belluoccio
Wilson
Thornton
D.J.
Wallis
Gorman
J.J.
mouse
plate
cartilage.Proteomics.
6549-6553Crossref
(30)
56Hansen
Kiemele
O'Brien
Shankar
Fornetti
al.An
in-solution
ultrasonication-assisted
digestion
improved
proteome
coverage.Mol.
8:
1648-1657Abstract
(85)
Of
note,
sample
preparation
protocols
tailored
account
posed
(insolubility,
glycosylation),
separation
1D
resulted
identification
nearly
100
distinct
(57Didangelos
Yin
X.
Mandal
Baumert
Jahangiri
Mayr
Proteomics
space
components
human
aorta.Mol.
2048-2062Abstract
(214)
58Didangelos
Saje
Smith
Xu
Q.
abdominal
aortic
aneurysms:
approach.Mol.
10https://doi.org/10.1074/mcp.M111.008128Abstract
(146)
However,
most
studies,
known
proteins,
expected
detected
those
were
identified.
One
then
ask:
ensure
capturing
tissues?
And
indeed,
faced
when
attempting
characterize,
unbiased
manner,
lack
defined
parts
systematically
annotate
experimental
output.
result,
days
proteomics,
listed
"ECM"
involved
adhesions
incorporated
Conversely,
prior
knowledge
existed
would
fail
annotated
belonging
represented
any
attempt
aiming
states.
became
obvious
analytical
decipher
discuss
enhancement
purpose
biomarker
target
focus
Special
Issue
Clinical
Proteomics,
article
highlight
selected
performed
samples
rodent
models
show
promise.
organisms,
zebrafish
(59Chen
W.C.W.
Wang
Missinato
Park
Long
Liu
H.J.
al.Decellularized
cardiac
mammalian
heart
regeneration.Sci.
Adv.
2e1600844Crossref
(83)
60Garcia-Puig
Mosquera
Jiménez-Delgado
García-Pastor
Jorba
Navajas
al.Proteomics
regeneration.Mol.
1745-1755Abstract
61Kessels
M.Y.
Huitema
L.F.A.
Boeren
Kranenbarg
Schulte-Merker
Leeuwen
JL
skeletal
matrix.PLoS
One.
9e90568Crossref
(32)
drosophila
(62Sessions
A.O.
Kaushik
Parker
Raedschelders
Bodmer
Eyk
downregulation
Drosophila
preserves
contractile
function
improves
lifespan.Matrix
2017;
62:
15-27Crossref
(15)
planarians
(63Sonpho
E.
Mann
F.G.
Levy
Ross
Guerrero-Hernández
Florens
al.Decellularization
Enables
planarian
20100137Abstract
produced
culture.
advance
fundamental
disease.
bottom-up
MS-based
but,
worth
noting
modalities
facets
glycosylation
patterns
glycomics
(64Raghunathan
Sethi
M.K.
Klein
Zaia
glycomics,
glycoproteomics
molecules.Mol.
2138-2148Abstract
(29)
65de
Haan
Pučić-Baković
Novokmet
Falck
Lageveen-Kammeijer
Razdorov
al.Developments
perspectives
high-throughput
glycomics:
enabling
thousands
samples.Glycobiology.
32:
651-663Crossref
66Kellman
B.P.
Lewis
N.E.
Big-data
tools
connect
glycan
biosynthesis
communication.Trends
46:
284-300Abstract
(23)
67Riley
N.M.
Bertozzi
C.R.
Pitteri
S.J.
A
pragmatic
spectrometry-based
glycoproteomics.Mol.
20100029Abstract
fragments
degradomics
(68Haack
Overall
C.M.
auf
dem
Keller
Degradomics
technologies
exploration.Matrix
114:
1-17Crossref
localization
distribution
MS
(69Angel
P.M.
Comte-Walters
Ball
L.E.
Talbot
Brockbank
K.G.M.
al.Mapping
formalin-fixed,
paraffin-embedded
MALDI
spectrometry.J.
Proteome
635-646Crossref
(51)
70Clift
C.L.
Drake
R.R.
Angel
Multiplexed
serial
enzyme
digests
formalin-fixed
sections.Anal.
Bioanal.
Chem.
413:
2709-2719Crossref
(8)
2012,
published
journal
describing
two-pronged
(71Naba
Clauser
K.R.
Hoersch
Carr
Hynes
matrisome:
silico
definition
normal
matrices.Mol.
11https://doi.org/10.1074/mcp.M111.014647Abstract
(668)
While
had
attempted
limitations
described
above
decellularizing
extracting
guanidine
hydrochloride),
set
tackle
them
all.
brief,
took
differential
solubility
deplete
non-ECM
incubations
extraction,
decellularization,
buffers
concomitantly
enriching
Observing
incubation
8
M
urea
mM
DTT
did
fully
solubilize
ECM-enriched
suspecting
found
material,
processed
"crude"
M-urea-resuspended
samples.
We
hypothesized
deglycosylating
enhance
accessibility
treated
Peptide-N-glycosidase
F
(PNGaseF).
further
preincubated
deglycosylated
suspension
LysC,
protease
digesting
tightly
folded
tryptic
digestion.
To
fractionated
off-gel
electrophoresis.
Last,
quantification
stipulated
ECM-specific
PTMs
hydroxylations
variable
database
search.
Indeed,
19%
acid
sequence
I
positions
X
Y
X-Y-Gly
repeats
often
hydroxylated
parallel,
developed
robust
nomenclature
classify
characteristic
domain-based
organization
(72Hohenester
Eng
Language: Английский
Design and engineering of organ-on-a-chip
Biomedical Engineering Letters,
Journal Year:
2023,
Volume and Issue:
13(2), P. 97 - 109
Published: Jan. 2, 2023
Language: Английский
CAF-induced physical constraints controlling T cell state and localization in solid tumours
Nature reviews. Cancer,
Journal Year:
2024,
Volume and Issue:
24(10), P. 676 - 693
Published: Sept. 9, 2024
Language: Английский
Advancement of Scaffold-Based 3D Cellular Models in Cancer Tissue Engineering: An Update
Frontiers in Oncology,
Journal Year:
2021,
Volume and Issue:
11
Published: Oct. 25, 2021
The
lack
of
traditional
cancer
treatments
has
resulted
in
an
increased
need
for
new
clinical
techniques.
Standard
two-dimensional
(2D)
models
used
to
validate
drug
efficacy
and
screening
have
a
low
Language: Английский